Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation
Terminated
- Conditions
- Liver Transplantation
- Interventions
- Device: ECOM ETT
- Registration Number
- NCT01299441
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to determine whether the endotracheal cardiac output monitor (ECOM) is accurate and predictive in liver failure patients with hyperdynamic circulatory changes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Patients undergoing liver transplantation surgery
Read More
Exclusion Criteria
- Patients who are anticipated to remain intubated postoperatively for greater than 24 hours.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description OLT patients intubated with ECOM ETT ECOM ETT Patients undergoing liver transplantation and intubated with ECOM endotracheal tube (ETT).
- Primary Outcome Measures
Name Time Method endotracheal cardiac output monitor (ECOM), a non-invasive cardiac output monitor, is accurate and predictive Less than 24 hours Pulmonary artery catheters are a standard of care for intraoperative hemodynamic assessment during liver transplantation. We propose to compare hemodynamic parameters obtained from PA catheters and ECOM. Use the endotracheal cardiac output monitor (ECOM) to evaluate multiple hemodynamic parameters (invasive blood pressure from the indwelling arterial catheter, noninvasive cardiac output via ECOM), and compare these to the parameters obtained from PA catheter.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Jacksonville, Florida, United States